<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82128">
  <stage>Registered</stage>
  <submitdate>1/07/2007</submitdate>
  <approvaldate>3/07/2007</approvaldate>
  <actrnumber>ACTRN12607000356460</actrnumber>
  <trial_identification>
    <studytitle>The split thickness skin graft donor site; A comparative study of Tegaderm Absorbent and Kaltostat Alginate dressings</studytitle>
    <scientifictitle>The split thickness skin graft donor site; A prospective randomised controlled trial that demonstrates improved rates of healing, reduced pain and superior ease of management with Tegaderm Absorbent in comparision to Kaltostat aliginate dressings.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Split thickness skin graft donor sites</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Comparative study of 2 dressings - Contol dresssing; Kaltostat Alginate . New dressing on trial; Tegaderm Absorbent. . The first donor site dressing assessment is done 10-14 days postoperatively and subsequent dressings are done weekly thereafter till fully healed. Maximum duration 4 weeks / average duration 14 days.</interventions>
    <comparator>Contol dresssing; Kaltostat Alginate.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Rate of Healing.</outcome>
      <timepoint>The first donor site dressing assessment is done 10 - 14 days postoperatively and subsequent dressings are done weekly thereafter till fully healed. Maximum duration 4 weeks / average duration 14 days.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Reduced pain </outcome>
      <timepoint>On day 1 &amp; 2 postoperatively and with dressing changes (visual analogue scales 1-10).</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Leakage from dressings  </outcome>
      <timepoint>Observed in the first 2 weeks post surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ease of Management </outcome>
      <timepoint>Patients questioned at their first dressing assessment as to difficulty with showering, walking etc.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients requiring a split thickness skin graft to be harvested from their thigh</inclusivecriteria>
    <inclusiveminage>10</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients with allergies to Polyurethrane film dressings or Mefix tape.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sequential patients requiring a skin graft on arriving in theatre are allocated a dressing according to the randomisation chart</concealment>
    <sequence>Monash Uni Statistician created a computer generated randomisation chart for us</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>7/07/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Patricia terrill</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Peninsular Health (Frankston Hospital)</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A trial has been carried out comparing a new dressing Tegaderm Absorbent with Kaltostat alginate dressing for use on the skin graft donor site.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Peninsula health-Peninsula private Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>5/07/2006</ethicapprovaldate>
      <hrec>TRIAL 2006-32</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Patricia Terrill</name>
      <address>No 29 Specialist Centre
29 Hastings road
Frankston 3199</address>
      <phone>+61 3 97696056</phone>
      <fax>+61 3 97696057</fax>
      <email>pjterril@bigpond.net.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Patricia Terrill</name>
      <address>No 29 Specialist Centre
29 Hastings Road
Frankston 3199 (this is the best contact address)
OR
Frankston Hospital
PO Box 52 Frankston 3199</address>
      <phone>+61 3 97696056 OR frankston hospital 97847777</phone>
      <fax>+61 3 97696057</fax>
      <email>n/a</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>